Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07574073
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related CytopeniaQi dengNot Yet RecruitingPhase 1
NCT07574073Not Yet Recruiting
Phase 1
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refrac...Qi deng
NCT07573371
Understanding and Tailored Treatment of Low Anterior Resection SyndromeAalborg University HospitalRecruiting
NCT07573371Recruiting
—
Understanding and Tailored Treatment of Low Anterior Resection SyndromeAalborg University Hospit...
NCT07574268
Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men With Erectile Dysfunction: A Randomized, Double-Blind, Bi-centric, Placebo- and Sham-Controlled TrialMenoufia UniversityCompletedPhase 4
NCT07574268Completed
Phase 4
Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men Wi...Menoufia University
NCT07572357
Clinical Evaluation of the RH210 Hearing AidGlobal Edge Medtech ConsultingNot Yet RecruitingNot Applicable
NCT07572357Not Yet Recruiting
Not Applicable
Clinical Evaluation of the RH210 Hearing AidGlobal Edge Medtech Consu...
NCT07574320
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel SyndromeMd. Aminul IslamNot Yet RecruitingPhase 4
NCT07574320Not Yet Recruiting
Phase 4
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndr...Md. Aminul Islam
NCT07573072
Characterization of the Methylation Profile of Stored Human SamplesIstituto Ortopedico RizzoliCompleted
NCT07573072Completed
—
Characterization of the Methylation Profile of Stored Human SamplesIstituto Ortopedico Rizzo...
NCT07574242
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 UniversityCompletedNot Applicable
NCT07574242Completed
Not Applicable
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 University
NCT07572318
Pilot Study on the Feasibility of High-energy Collimation With Optimized Geometry on a VERITON™ CZT CameraCentral Hospital, Nancy, FranceNot Yet RecruitingNot Applicable
NCT07572318Not Yet Recruiting
Not Applicable
Pilot Study on the Feasibility of High-energy Collimation With Optimized Geometr...Central Hospital, Nancy,...
NCT07572539
The Accuracy of Peripheral Perfusion Index and Inferior Vena Cava Collapsibility Index for Predicting Hypotension in Patients Undergoing Shoulder Arthroscopy in Beach Chair Position:Tanta UniversityActive Not Recruiting
NCT07572539Active Not Recruiting
—
The Accuracy of Peripheral Perfusion Index and Inferior Vena Cava Collapsibility...Tanta University
NCT07572305
Effects of Virtual Reality After Liver TransplantationMalatya Turgut Ozal UniversityCompletedNot Applicable
NCT07572305Completed
Not Applicable
Effects of Virtual Reality After Liver TransplantationMalatya Turgut Ozal Unive...
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07572071
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's DiseaseIran University of Medical SciencesRecruitingPhase 1
NCT07572071Recruiting
Phase 1
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Park...Iran University of Medica...
NCT07574307
Kinesiotaping in Isolated Meniscus InjuriesBandırma Onyedi Eylül UniversityRecruitingNot Applicable
NCT07574307Recruiting
Not Applicable
Kinesiotaping in Isolated Meniscus InjuriesBandırma Onyedi Eylül Uni...
NCT07572747
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf CountriesKhalid F AlhabibNot Yet RecruitingPhase 3
NCT07572747Not Yet Recruiting
Phase 3
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countrie...Khalid F Alhabib
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572058
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLCNot Yet RecruitingNot Applicable
NCT07572058Not Yet Recruiting
Not Applicable
Large Diameter Visigi LUX Gastric Sizing and Calibration SystemBoehringer Labs LLC
NCT07571967
AI-Assisted Camera-Based Progressive Muscle Relaxation for Office WorkersIstanbul Medipol University HospitalRecruitingNot Applicable
NCT07571967Recruiting
Not Applicable
AI-Assisted Camera-Based Progressive Muscle Relaxation for Office WorkersIstanbul Medipol Universi...
NCT07572045
Promoting Interventions for Climate Change to Upscale Resilience in District BadinDr Jai Kumar DasNot Yet RecruitingNot Applicable
NCT07572045Not Yet Recruiting
Not Applicable
Promoting Interventions for Climate Change to Upscale Resilience in District Bad...Dr Jai Kumar Das
NCT07572461
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Peripheral Neuropathy Induced by Taxane-Based ChemotherapySecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNot Yet RecruitingNot Applicable
NCT07572461Not Yet Recruiting
Not Applicable
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Pe...Second Affiliated Hospita...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting4 (20%)
Completed4 (20%)
Active, not recruiting1 (5%)
not_applicable11 (55%)
Not Specified3 (15%)
Phase 12 (10%)
Phase 42 (10%)
Phase 31 (5%)
Phase 21 (5%)